News and History
-
FDA Announces Approval of Cytokinetics’ MYQORZO™ (aficamten) for Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy
Read More: FDA Announces Approval of Cytokinetics’ MYQORZO™ (aficamten) for Treatment of Adults with Symptomatic Obstructive Hypertrophic CardiomyopathyOn Dec. 19, 2025, Cytokinetics announced that the U.S. Food and Drug Administration (FDA) has approved MYQORZO™ (aficamten),…
-
BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Position as a Leader in Rare Diseases
Read More: BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Position as a Leader in Rare DiseasesOn Dec. 19, 2025, BioMarin Pharmaceutical and Amicus Therapeutics announced that BioMarin has entered into a definitive agreement…
-
CRISPR primes goldenberry for fruit bowl fame
Read More: CRISPR primes goldenberry for fruit bowl fameOn Dec. 19, 2025, Cold Spring Harbor Laboratory (CSHL) plant biologists may have found a “shortcut” to this…
-
WHO validates Brazil for eliminating mother-to-child transmission of HIV
Read More: WHO validates Brazil for eliminating mother-to-child transmission of HIVOn Dec. 18, 2025, the World Health Organization (WHO) announced it has validated Brazil for the elimination of…
-
Chronic Disease Could Cost the U.S. $47 Trillion Over Next 15 Years
Read More: Chronic Disease Could Cost the U.S. $47 Trillion Over Next 15 YearsOn Dec. 18, 2025, new national and state data was released by the Partnership to Fight Chronic Disease…
-
Space Station Research Supports New FDA-Approved Cancer Therapy
Read More: Space Station Research Supports New FDA-Approved Cancer TherapyOn Dec. 18, 2025, the National Aeronautics and Space Administration (NASA) announced it has opened the International Space…
-
Novo Nordisk files for FDA approval of CagriSema, the first once-weekly combination of GLP‑1 and amylin analogues for weight management
Read More: Novo Nordisk files for FDA approval of CagriSema, the first once-weekly combination of GLP‑1 and amylin analogues for weight managementOn Dec. 18, 2025, Novo Nordisk announced the submission of a New Drug Application (NDA) to the U.S….
-
Israeli, US scientists uncover viral switch that could help defeat antibiotic resistance
Read More: Israeli, US scientists uncover viral switch that could help defeat antibiotic resistanceOn Dec. 18, 2025, scientists at the Hebrew University of Jerusalem revealed that bacteriophages use a small RNA…
-
How common is Alzheimer’s? Blood-test study holds surprises
Read More: How common is Alzheimer’s? Blood-test study holds surprisesOn Dec. 17, 2025, A survey of Alzheimer’s disease prevalence in Norway confirms earlier estimates and might show…
-
Detailed cell map unlocks secrets of how reproductive organs form
Read More: Detailed cell map unlocks secrets of how reproductive organs formOn Dec. 17, 2025, new research has mapped the cell types that specialise to form reproductive organs in…
-
University Engineers create robots barely visible to the naked eye that operate autonomously
Read More: University Engineers create robots barely visible to the naked eye that operate autonomouslyOn Dec. 17, 2025, researchers at the University of Pennsylvania’s (UPenn) School of Engineering and Applied Science, and…
-
US NIH races to fill nearly half its top roles after wave of departures
Read More: US NIH races to fill nearly half its top roles after wave of departures -
Adaptive Inks deals with Pfizer to support research in rheumatoid arthritis and other immune-related diseases woth $890 Million
Read More: Adaptive Inks deals with Pfizer to support research in rheumatoid arthritis and other immune-related diseases woth $890 MillionOn Dec. 15, 2025, Adaptive Biotechnologies announced it has signed two non-exclusive deals with Pfizer to support research…
-
GigaTIME AI tool advances cancer research and could unlock access to better treatment
Read More: GigaTIME AI tool advances cancer research and could unlock access to better treatmentOn Dec. 15, 2025, Microsoft Research announced a new AI tool developed by and published in Cell allows…
-
National Science Foundation softens grant-review rules to cope with backlog
Read More: National Science Foundation softens grant-review rules to cope with backlogOn Dec. 15, 2025, the U.S. National Science Foundation (NSF) is relaxing some of its requirements for the…
-
Highly Pathogenic Avian Influenza Detected in Shelby County Commercial Flock
Read More: Highly Pathogenic Avian Influenza Detected in Shelby County Commercial FlockOn Dec. 12, 2025, the Texas Animal Health Commission (TAHC) and the United States Department of Agriculture’s (USDA)…
-
FDA Approves Two Oral Therapies to Treat Gonorrhea
Read More: FDA Approves Two Oral Therapies to Treat GonorrheaOn Dec. 12, 2025, the U.S. Food and Drug Administration (FDA) announced it has approved two new oral…
-
Flu, RSV activity rising in US and Europe, with major UK surge in flu cases
Read More: Flu, RSV activity rising in US and Europe, with major UK surge in flu casesOn Dec. 12, 2025, the Center for Infectious Disease Research & Policy (CIDRAP) reported COVID-19 rates in the…
-
Hundreds are quarantined in South Carolina as measles spreads in 2 US outbreaks
Read More: Hundreds are quarantined in South Carolina as measles spreads in 2 US outbreaksOn Dec. 11, 2025, measles outbreaks are growing along the Utah-Arizona border and in South Carolina, where hundreds…
-
CIRM approves over $160M to support preclinical and clinical research, advances education opportunities and access to clinical trials
Read More: CIRM approves over $160M to support preclinical and clinical research, advances education opportunities and access to clinical trialsOn Dec. 11, 2025, the California Institute for Regenerative Medicine (CIRM) governing board approved funding of over $160…
